Cognitive behavioral interventions for depression and anxiety in adults with neurological disorders: a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 105 of the 108 references it cites were found in a registry or an index; 7 of the 12 sources its claims cite were checked for support.
Abstract
We examined the efficacy of cognitive and behavioral interventions for improving symptoms of depression and anxiety in adults with neurological disorders. A pre-registered systematic search of Cochrane Central Register of Controlled Trials, MEDLINE, PsycINFO, Embase, and Neurobite was performed from inception to May 2024. Randomized controlled trials (RCTs) which examined the efficacy of cognitive and behavioral interventions in treating depression and/or anxiety among adults with neurological disorders were included. Estimates were pooled using a random-effects meta-analysis. Subgroup analyses and meta-regression were performed on categorical and continuous moderators, respectively. Main outcomes were pre- and post-intervention depression and anxiety symptom scores, as reported using standardized measures. Fifty-four RCTs involving 5372 participants with 11 neurological disorders (including multiple sclerosis, epilepsy, stroke) were included. The overall effect of interventions yielded significant improvements in both depression (57 arms, Hedges' g = 0.45, 95% confidence interval [CI] 0.35-0.54) and anxiety symptoms (29 arms, g = 0.38, 95% CI 0.29-0.48), compared to controls. Efficacy was greater in studies which employed a minimum baseline symptom severity inclusion criterion for both outcomes, and greater in trials using inactive controls for depression only. There was also evidence of differential efficacy of interventions across the neurological disorder types and the outcome measure used. Risk of bias, intervention delivery mode, intervention tailoring for neurological disorders, sample size, and study year did not moderate effects. Cognitive and behavioral interventions yield small-to-moderate improvements in symptoms of both depression and anxiety in adults with a range of neurological disorders. © The Author(s), 2024.
Overview
CoChat Summary
TL;DR
This systematic review and meta-analysis found that cognitive and behavioral interventions were associated with small-to-moderate improvements in depression and small improvements in anxiety among adults with neurological disorders. Effects varied by neurological disorder and outcome measure, while delivery mode, tailoring, sample size, study year, and risk of bias did not moderate effects.
Key findings
- The review included 54 RCTs with 5,372 participants; the overall pooled effect was g = 0.45 for depression (95% CI 0.35–0.54, p < 0.001) across 57 treatment arms, and g = 0.38 for anxiety (95% CI 0.29–0.48, p < 0.001) across 29 treatment arms.
- Depression effects were substantially heterogeneous (I² = 64.60, p < 0.001), while anxiety effects showed low, nonsignificant heterogeneity (I² = 27.70, p = 0.09).
- Depression effects differed by neurological disorder, with the largest effects in Parkinson’s disease (g = 0.88, k = 7), multiple sclerosis (g = 0.57, k = 14), and migraine (g = 0.50, k = 4); smaller effects were found in epilepsy (g = 0.34, k = 9), TBI (g = 0.31, k = 7), and stroke (g = 0.28, k = 10).
- Anxiety effects also differed by disorder: Parkinson’s disease (g = 0.64, k = 6), multiple sclerosis (g = 0.41, k = 7), migraine (g = 0.42, k = 4), and epilepsy (g = 0.20, k = 5) were significant, but TBI was nonsignificant (g = 0.20, 95% CI −0.09 to 0.49; k = 4).
Methods
- Systematic review and meta-analysis conducted per PRISMA, with protocol prospectively registered on PROSPERO (CRD42022351547); databases searched were CENTRAL, MEDLINE, PsycINFO, Embase, and Neurobite from inception to May 2024.
- Included studies were RCTs of cognitive/behavioral interventions in adults with neurological disorders, with at least 20 participants per arm at randomization, targeting depression and/or anxiety with pre- and post-intervention standardized outcomes.
- Effect sizes were pooled using random-effects meta-analysis in Comprehensive Meta-Analysis v3.0, calculating Hedges’ g; moderators were tested with subgroup analyses and meta-regression, and publication bias was assessed with funnel plots, Egger’s test, and trim-and-fill.
Limitations
- The paper states that dropout was higher in intervention groups than controls (17% vs 11%), and 17 (30%) interventions had dropout rates ≥20%, raising concern for attrition bias.
- The paper states that 43% of studies had high risk of bias, and that missing data handling/intent-to-treat analysis was not consistently done or clearly reported.
- Evidence evident from the text: subgroup analyses may be underpowered, follow-up periods varied too much to assess durability, and the authors could not include nine trials because of missing data; they also note limited diversity, with among studies reporting race, most participants being White/Caucasian (~86%).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
6 Valid · 0 Not valid · 2 Not checked · 32 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The magnitude of these effects are consistent with several smaller disorder-specific meta-analyses in PD (Ghielen et al., 2019), MS (Hind et al., 2014), and epilepsy (Li et al., 2023), as well as in adults with long-term physical health conditions (Scott et al., 2023).”
§ Cognitive behavioral interventions for depression and anxiety in adults with neurological disorders: a systematic review and meta-analysis > Discussion
What the sources say
- Supportedcites Ghielen et al., 2019 matched to “The effects of cognitive behavioral and mindfulness-based therapies on psychological distress in patients with multiple sclerosis, Parkinson's disease and Huntington's disease: Two meta-analyses” (2019) source
The citation to Ghielen et al. supports the Parkinson’s disease part of the sentence, not the separately cited MS, epilepsy, or long-term-condition parts. Table 2 (section 4.2, page unavailable) reports a PD subgroup effect size of g = 0.37 from four studies, consistent with the claimed magnitude; its wide confidence interval (−0.55 to 1.29) makes that estimate uncertain. (LLM, conf=0.87)
- Supportedcites Hind et al., 2014 matched to “Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis” (2014) source
The Discussion (Principal findings; page unavailable) describes a medium treatment effect of about 0.5 standard deviations for CBT on depression in people with MS. The Results (Synthesis; page unavailable) also reports an effect of 0.46 standard deviations after removal of an outlying study. This supports the citation’s use of Hind et al. as an MS-specific meta-analysis reporting an effect of that magnitude; it does not itself compare the citing paper’s effects. (LLM, conf=0.88)
- Not matchedcites Li et al., 2023
This doesn’t read as a citation we can look up.
plainstates an associationn = 5,372- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Our effect size for depression was similar to that identified in a meta-analysis of antidepressants for NDs (Price et al., 2011), which mirrors the short-term clinical equivalence of psychological and pharmacological treatments observed in the general population (Cuijpers et al., 2023).”
§ Cognitive behavioral interventions for depression and anxiety in adults with neurological disorders: a systematic review and meta-analysis > Discussion
What the sources say
- Not checked — no full text of the sourcecites Price et al., 2011 matched to “Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials” (2011) source
- Supportedcites Cuijpers et al., 2023 matched to “Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta‐analysis including 409 trials with 52,702 patients” (2023) source
The Abstract and Discussion of Cuijpers et al. (2023) state that 'The effects of CBT did not differ significantly from those of pharmacotherapies at the short term' and that 'CBT appears to be as effective as pharmacotherapies at the short term, but more effective at the longer term', which is exactly the short-term psychological–pharmacological equivalence the citing sentence invokes. The Results section ('CBT versus pharmacotherapies and combined treatment') backs this with the head-to-head pooled estimate g=0.08 (95% CI: -0.07 to 0.24) across 38 comparisons in adults with depression (i.e. the general, non-neurological population). The paper's own conclusion qualifies the equivalence as short-term only, and the citing sentence carries the same 'short-term' qualifier, so no part of what is attributed is unsupported. (LLM, conf=0.85)
plainn = 5,372- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Nevertheless, our benchmarks of observed clinical effects are more modest than the moderate effects observed for psychological interventions for people within the general or ‘healthy’ population (Cuijpers et al., 2023).”
§ Cognitive behavioral interventions for depression and anxiety in adults with neurological disorders: a systematic review and meta-analysis > Discussion
What the sources say
- Partly supportedcites Cuijpers et al., 2023 matched to “Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta‐analysis including 409 trials with 52,702 patients” (2023) sourceExperimental — accuracy not yet measured
Our copy of Cuijpers et al. (2023) reports moderate effect sizes for CBT only in subsets of people with depression — 'moderate effect (g=0.41)' for children and adolescents and 'small to moderate effect (g=0.45)' for unguided self-help CBT (Other comparisons; Table 5), with the main CBT-vs-control effect described as moderate to large (g=0.79, CBT versus control conditions; Table 2). It contains no benchmark for psychological interventions in the general or 'healthy' population: trials were selected only where CBT was given 'for people with depression' and 'Depression not inclusion criterion (n=484)' was an exclusion reason (Identification and selection of trials; Figure 1/PRISMA list). The unsupported part of the attributed claim is therefore the general/'healthy'-population comparison; only the 'moderate effects of psychological interventions' element is present, and in clinical/depressed samples. (LLM, conf=0.68)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, those requiring a diagnosis or symptoms above a clinical cut-off at baseline reported greater intervention effects, specifically moderate effects for both depression (g = 0.54, 95% CI 0.39–0.70) and anxiety (g = 0.51, 95% CI 0.35–0.67), compared to small effects observed in those without a baseline symptom criterion (g = 0.32, 95% CI 0.24–0.40; g = 0.28, 95% CI 0.18–0.39 respectively).”
§ Cognitive behavioral interventions for depression and anxiety in adults with neurological disorders: a systematic review and meta-analysis > Results > Moderator analyses
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, those requiring a diagnosis or symptoms above a clinical cut-off at baseline reported greater intervention effects, specifically moderate effects for both depression (g = 0.54, 95% CI 0.39–0.70) and anxiety (g = 0.51, 95% CI 0.35–0.67), compared to small effects observed in those without a baseline symptom criterion (g = 0.32, 95% CI 0.24–0.40; g = 0.28, 95% CI 0.18–0.39 respectively).”
§ Cognitive behavioral interventions for depression and anxiety in adults with neurological disorders: a systematic review and meta-analysis > Results > Moderator analyses
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
11 more claims
Create a free account to see all 40 claims and every source verdict.
- It may state two separate claims as one. 18
- Probably not a substantial claim. 8
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cognitive behavioral interventions for depression and anxiety in adults with neurological disorders: a systematic review and meta-analysis > Results > Risk of bias
“Most studies (k = 24; 44%) had an overall high risk of bias, 20 (37%) indicated some concern, and 10 (19%) were low risk.”
§ Cognitive behavioral interventions for depression and anxiety in adults with neurological disorders: a systematic review and meta-analysis > Discussion > Limitations
“However, this was not consistently done or clearly reported, contributing to many studies (43%) having a high RoB.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cognitive behavioral interventions for depression and anxiety in adults with neurological disorders: a systematic review and meta-analysis > Results > Study characteristics
“Most studies used inactive control groups (k = 41; 76%), including 23 (43%) treatment-as-usual or usual care groups and 18 (33%) waitlist-control groups.”
§ Cognitive behavioral interventions for depression and anxiety in adults with neurological disorders: a systematic review and meta-analysis > Discussion
“Most studies utilized an inactive control group (k = 44; 76%). The remaining 12 studies used a form of active control, typically forms of education.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cognitive behavioral interventions for depression and anxiety in adults with neurological disorders: a systematic review and meta-analysis > Results > Study characteristics
“Race/ethnicity was reported in 18 studies (52%), mostly from the USA (k = 14).”
§ Cognitive behavioral interventions for depression and anxiety in adults with neurological disorders: a systematic review and meta-analysis > Discussion > Limitations
“Finally, across 14 studies to report race, most reported a high proportion of White/Caucasian participants (~86%), which raises concerns about the diversity of samples.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cognitive behavioral interventions for depression and anxiety in adults with neurological disorders: a systematic review and meta-analysis > Discussion > Limitations
“Despite contacting authors, we were unable to include nine trials due to missing data.”
§ Cognitive behavioral interventions for depression and anxiety in adults with neurological disorders: a systematic review and meta-analysis > Methods > Data extraction
“At least two attempted contacts were made with authors of 16 studies which were eligible but omitted data required for the meta-analysis; two authors were not contactable. Of the 14 successfully contacted, eight responded (57% response rate) with six of these providing data which was used in the analyses.”
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223 · cited 1×
“This study was completed in compliance with the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) Checklist (Moher et al., 2015).”
MethodRayyan-a web and mobile app for systematic reviews.
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0384-4 · Cited by 26,092 · cited 1×
“One author (T.W.) screened all titles and abstracts using Rayyan (Ouzzani, Hammady, Fedorowicz, & Elmagarmid, 2016), with a random 20% blind reviewed by a second author (M.G.) to verify the accuracy of the screening process.”
MethodDermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099 · cited 1×
“Trim-and-fill analysis was used to estimate the number of unpub-lished studies and provide an adjusted effect estimate if they were included (Duval & Tweedie, 2000).”
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020124 · Cited by 10,505
Simmons, J. P., Nelson, L. D., & Simonsohn, U. (2011) · Psychological Science · doi:10.1177/0956797611417632 · Cited by 6,567
Outlier and influence diagnostics for meta-analysis
Viechtbauer, W., & Cheung, M. W.-L. (2010) · Research Synthesis Methods · doi:10.1002/jrsm.11 · Cited by 2,949 · cited 1×
“The influence of outliers on the pooled effect was examined using the ‘ one study removed ’ procedure (Harrer et al., 2021; Viechtbauer & Cheung, 2010).”
MethodAnalysing data and undertaking meta‐analyses
Deeks, J. J., Higgins, J. P., Altman, D. G., & on behalf of the Cochrane Statistical Methods Group (2019) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9781119536604.ch10 · Cited by 2,672 · cited 2×
“We interpreted g values of 0.2, 0.5, and 0.8 to indicate small, moderate, and large effects, respectively (Deeks, Higgins, & Altman, 2019).”
InfluentialDoing Meta-Analysis with R: A Hands-On Guide
Harrer, M., Cuijpers, P., Furukawa, T. A., & Ebert, D. D. (2021) · doi:10.1201/9781003107347 · Cited by 1,850 · cited 1×
“The influence of outliers on the pooled effect was examined using the ‘ one study removed ’ procedure (Harrer et al., 2021; Viechtbauer & Cheung, 2010).”
MethodTransdiagnostic approaches to mental health problems: Current status and future directions.
Dalgleish, T., Black, M., Johnston, D., & Bevan, A. (2020) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000482 · Cited by 883 · cited 1×
“This gap is notable given the rise in trans-diagnostic interventions, which aim to address both sets of symptoms (Dalgleish, Black, Johnston, & Bevan, 2020).”
BackgroundNeuro-QOL: Brief measures of health-related quality of life for clinical research in neurology
Cella, D., Lai, J.-S., Nowinski, C. J., Victorson, D., Peterman, A., Miller, D., Bethoux, F., Heinemann, A., Rubin, S., Cavazos, J. E., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318258f744 · Cited by 785
Internet-delivered psychological treatments: from innovation to implementation
Andersson, G., Titov, N., Dear, B. F., Rozental, A., & Carlbring, P. (2019) · World Psychiatry · doi:10.1002/wps.20610 · Cited by 750 · cited 1×
“These results are promising considering the upsurge in teletherapy since the COVID-19 pandemic (Meininger et al., 2022) and general paradigm shift toward digital mental health interventions (Andersson, Titov, Dear, Rozental, & Carlbring, 2019).”
ResultSelf-citationSample size slippages in randomised trials: exclusions and the lost and wayward.
Schulz, K. F., & Grimes, D. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07882-0 · Cited by 642
Cuijpers, P., Miguel, C., Harrer, M., Plessen, C. Y., Ciharova, M., Ebert, D., & Karyotaki, E. (2023) · World Psychiatry · doi:10.1002/wps.21069 · Cited by 354 · cited 3×
“The moderate effect sizes of those studies which used a severity criterion were more comparable to effect sizes observed in the general population (Cuijpers et al., 2023).”
BackgroundResultCognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial
Dobkin, R. D., Menza, M., Allen, L. A., Gara, M. A., Mark, M. H., Tiu, J., Bienfait, K. L., & Friedman, J. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111669 · Cited by 310 · cited 1×
“%) of the included PD trials were conducted by the same team, and reported large effects ( gs = 1.10 – 1.56) (Dobkin et al., 2011, 2020, 2021).”
BackgroundInfluentialTelephone-administered psychotherapy for depression
Mohr, D. C., Hart, S. L., Julian, L., Catledge, C., Honos-Webb, L., Vella, L., & Tasch, E. T. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.1007 · Cited by 298
Minden, S. L., Feinstein, A., Kalb, R. C., Miller, D., Mohr, D. C., Patten, S. B., Bever, C., Schiffer, R. B., Gronseth, G. S., & Narayanaswami, P. (2014) · Neurology · doi:10.1212/wnl.0000000000000013 · Cited by 230
Clinical practice guidelines for mild traumatic brain injury and persistent symptoms.
Marshall, S., Bayley, M. T., McCullagh, S., Velikonja, D., & Berrigan, L. I. (2012) · Europe PMC (PubMed Central) · Cited by 222
Hind, D., Cotter, J., Thake, A., Bradburn, M., Cooper, C., Isaac, C., & House, A. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-5 · Cited by 180 · cited 6×
“The moderate effect sizes of those studies which used a severity criterion were more comparable to effect sizes observed in the general population (Cuijpers et al., 2023).”
InfluentialCochrane’s risk of bias tool in the context of psychotherapy outcome research
Munder, T., & Barth, J. (2018) · Psychotherapy Research · doi:10.1080/10503307.2017.1411628 · Cited by 174 · cited 5×
“We omitted items relating to concealment of intervention allocation to participants, as this is accepted practice in meta-analyses of psychotherapy RCTs (Munder & Barth, 2018) given the inherent inability to blind participants to intervention.”
MethodInfluentialPonsford, J., Lee, N. K., Wong, D., McKay, A., Haines, K., Alway, Y., Downing, M., Furtado, C., & O'Donnell, M. L. (2016) · Psychological Medicine · doi:10.1017/s0033291715002640 · Cited by 173
Comorbidity between neurological illness and psychiatric disorders
Hesdorffer, D. C. (2016) · CNS Spectrums · doi:10.1017/s1092852915000929 · Cited by 170 · cited 1×
“Depression and anxiety are prevalent among people with neurological disorders (NDs) (Alsaadi et al., 2019; Hesdorffer, 2016; Whitney, Shapiro, Warschausky, Hurvitz, & Peterson, 2019) and impact quality of life and prognosis (Hesdorffer, 2016; Prisnie et al., 2018).”
A’Campo, L. E. I., Wekking, E. M., Kamminga, N. G. A., le Cessie, S., & Roos, R. A. C. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.07.009 · Cited by 154
Cognitive behavioral therapy for post-stroke depression: A meta-analysis
Wang, S.-B., Wang, Y.-Y., Zhang, Q.-E., Wu, S.-L., Ng, C. H., Ungvari, G. S., Chen, L., Wang, C.-X., Jia, F.-J., & Xiang, Y.-T. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.011 · Cited by 150 · cited 3×
“Finally, previous meta-analyses have not included clinical trials from the past five years (Barua et al., 2024; Ghielen et al., 2019; Hind et al., 2014; Wang et al., 2018).”
Thomas, S. A., Walker, M. F., Macniven, J. A., Haworth, H., & Lincoln, N. B. (2013) · Clinical Rehabilitation · doi:10.1177/0269215512462227 · Cited by 149
Fann, J. R., Bombardier, C. H., Vannoy, S., Dyer, J., Ludman, E., Dikmen, S., Marshall, K., Barber, J., & Temkin, N. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2014.3423 · Cited by 147
Fischer, A., Schröder, J., Vettorazzi, E., Wolf, O. T., Pöttgen, J., Lau, S., Heesen, C., Moritz, S., & Gold, S. M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00049-2 · Cited by 143
A Randomized Trial of a Web‐Based Intervention to Improve Migraine Self‐Management and Coping
Bromberg, J., Wood, M. E., Black, R. A., Surette, D. A., Zacharoff, K. L., & Chiauzzi, E. J. (2012) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.02031.x · Cited by 136
Ehde, D. M., Elzea, J. L., Verrall, A. M., Gibbons, L. E., Smith, A. E., & Amtmann, D. (2015) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2015.07.015 · Cited by 132
Gallagher, M., McLeod, H. J., & McMillan, T. M. (2019) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2016.1258367 · Cited by 131 · cited 2×
“…have been recommended in conjunction with cognitive remediation strategies to address functional difficulties that people with NDs experience (Gallagher et al., 2019), with evidence these combined treatments can improve quality of life, participation, and functioning in people with an ABI…”
BackgroundPEARLS depression treatment for individuals with epilepsy: A randomized controlled trial
Ciechanowski, P., Chaytor, N., Miller, J., Fraser, R., Russo, J., Unutzer, J., & Gilliam, F. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.06.003 · Cited by 130
Dobkin, R. D., Mann, S. L., Gara, M. A., Interian, A., Rodriguez, K. M., & Menza, M. (2020) · Neurology · doi:10.1212/wnl.0000000000009292 · Cited by 127 · cited 1×
“%) of the included PD trials were conducted by the same team, and reported large effects ( gs = 1.10 – 1.56) (Dobkin et al., 2011, 2020, 2021).”
InfluentialKarekla, M., Kasinopoulos, O., Neto, D. D., Ebert, D. D., Van Daele, T., Nordgreen, T., Höfer, S., Oeverland, S., & Jensen, K. L. (2019) · European Psychologist · doi:10.1027/1016-9040/a000349 · Cited by 117 · cited 1×
“Most studies used some form of intervention tailoring to suit people with NDs, which is recommended as best practice (Karekla et al., 2019; Sanders, Coppin, Moulson, Meola, & Meyrick, 2020).”
BackgroundBédard, M., Felteau, M., Marshall, S., Cullen, N., Gibbons, C., Dubois, S., Maxwell, H., Mazmanian, D., Weaver, B., Rees, L., et al. (2014) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0b013e3182a615a0 · Cited by 112
Belleville, S., Hudon, C., Bier, N., Brodeur, C., Gilbert, B., Grenier, S., Ouellet, M., Viscogliosi, C., & Gauthier, S. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15192 · Cited by 109
Brief group‐based acceptance and commitment therapy for stroke survivors.
Majumdar, S., & Morris, R. (2019) · British Journal of Clinical Psychology · doi:10.1111/bjc.12198 · Cited by 107
PACES in epilepsy: Results of a self‐management randomized controlled trial
Fraser, R. T., Johnson, E. K., Lashley, S., Barber, J., Chaytor, N., Miller, J. W., Ciechanowski, P., Temkin, N., & Caylor, L. (2015) · Epilepsia · doi:10.1111/epi.13052 · Cited by 103
Gandy, M., Pang, S. T. Y., Scott, A. J., Heriseanu, A. I., Bisby, M. A., Dudeney, J., Karin, E., Titov, N., & Dear, B. F. (2022) · PAIN · doi:10.1097/j.pain.0000000000002606 · Cited by 102 · cited 2×
“This is also the case for study related factors known to influence treatment effects including the type of control and outcome measures used, baseline symptom severity, and risk of bias (Gandy et al., 2022; Scott et al., 2023).”
BackgroundResultSelf-citationSchröder, J., Brückner, K., Fischer, A., Lindenau, M., Köther, U., Vettorazzi, E., & Moritz, S. (2014) · Epilepsia · doi:10.1111/epi.12833 · Cited by 96
Price, A., Rayner, L., Okon-Rocha, E., Evans, A., Valsraj, K., Higginson, I. J., & Hotopf, M. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.230862 · Cited by 90 · cited 2×
“These criteria are largely consistent with previous reviews of anti-depressant medications for NDs (Price et al., 2011).”
ResultBoele, F. W., Klein, M., Verdonck-de Leeuw, I. M., Cuijpers, P., Heimans, J. J., Snijders, T. J., Vos, M., Bosma, I., Tijssen, C. C., Reijneveld, J. C., et al. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2712-5 · Cited by 88
Graziano, F., Calandri, E., Borghi, M., & Bonino, S. (2014) · Clinical Rehabilitation · doi:10.1177/0269215513501525 · Cited by 87
Mula, M., Brodie, M. J., de Toffol, B., Guekht, A., Hecimovic, H., Kanemoto, K., Kanner, A. M., Teixeira, A. L., & Wilson, S. J. (2022) · Epilepsia · doi:10.1111/epi.17140 · Cited by 86
Effects of depression and anxiety on quality of life in five common neurological disorders
Prisnie, J. C., Sajobi, T. T., Wang, M., Patten, S. B., Fiest, K. M., Bulloch, A. G. M., Pringsheim, T., Wiebe, S., & Jette, N. (2018) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2018.03.009 · Cited by 82 · cited 4×
“Finally, previous meta-analyses have not included clinical trials from the past five years (Barua et al., 2024; Ghielen et al., 2019; Hind et al., 2014; Wang et al., 2018).”
BackgroundMethodInfluentialScott, A. J., Sharpe, L., Thayer, Z. C., Miller, L. A., Hunt, C. J., MacCann, C., Parratt, K. L., Nikpour, A., Wong, T. H., & Gandy, M. (2019) · Epilepsia · doi:10.1111/epi.16348 · Cited by 75 · cited 1×
“Indeed, concerns have been raised about the validity of generic self-report measures in NDs due to common somatic-symptom items (e.g. dizziness), which can be confounded by neurological symptoms (Cella et al., 2012; Scott et al., 2019).”
BackgroundSelf-citationGhielen, I., Rutten, S., Boeschoten, R. E., Houniet-de Gier, M., van Wegen, E. E. H., van den Heuvel, O. A., & Cuijpers, P. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.05.001 · Cited by 74 · cited 4×
“The magnitude of these effects are consistent with several smaller disorder-specific meta-analyses in PD (Ghielen et al., 2019), MS (Hind et al., 2014), and epilepsy (Li et al., 2023), as well as in adults with long-term physical health conditions (Scott et al., 2023).”
BackgroundMethodResultInfluentialLincoln, N. B., Yuill, F., Holmes, J., Drummond, A. E., Constantinescu, C. S., Armstrong, S., & Phillips, C. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511408753 · Cited by 73
Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled Trial
Moonen, A. J. H., Mulders, A. E. P., Defebvre, L., Duits, A., Flinois, B., Köhler, S., Kuijf, M. L., Leterme, A., Servant, D., de Vugt, M., et al. (2021) · Movement Disorders · doi:10.1002/mds.28533 · Cited by 71
Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT
Thomas, S. A., Drummond, A. E., Lincoln, N. B., Palmer, R. L., das Nair, R., Latimer, N. R., Hackney, G. L., Mandefield, L., Walters, S. J., Hatton, R. D., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23470 · Cited by 67
Martin, P. R., Aiello, R., Gilson, K., Meadows, G., Milgrom, J., & Reece, J. (2015) · Behaviour Research and Therapy · doi:10.1016/j.brat.2015.07.005 · Cited by 66
Cieza, A., Anczewska, M., Ayuso‐Mateos, J. L., Baker, M. G., Bickenbach, J., Chatterji, S., Hartley, S. D., Leonardi, M., & Pitkänen, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136271 · Cited by 66 · cited 1×
“These include challenges associated with a lack of independence and sleep disturbances, and vulnerabilities associated with coping styles and cognitive difficulties (Cieza et al., 2015; Gandy et al., 2021).”
BackgroundPotter, S. D. S., Brown, R. G., & Fleminger, S. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-312838 · Cited by 66
Visser, M. M., Heijenbrok-Kal, M. H., van‘t Spijker, A., Lannoo, E., Busschbach, J. J. V., & Ribbers, G. M. (2016) · Stroke · doi:10.1161/strokeaha.115.010961 · Cited by 60
Bell, K. R., Fann, J. R., Brockway, J. A., Cole, W. R., Bush, N. E., Dikmen, S., Hart, T., Lang, A. J., Grant, G., Gahm, G., et al. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2016.4444 · Cited by 59
Whitney, D. G., Shapiro, D. N., Warschausky, S. A., Hurvitz, E. A., & Peterson, M. D. (2018) · Annals of Epidemiology · doi:10.1016/j.annepidem.2018.11.003 · Cited by 56 · cited 1×
“Depression and anxiety are prevalent among people with neurological disorders (NDs) (Alsaadi et al., 2019; Hesdorffer, 2016; Whitney, Shapiro, Warschausky, Hurvitz, & Peterson, 2019) and impact quality of life and prognosis (Hesdorffer, 2016; Prisnie et al., 2018).”
BackgroundBogosian, A., Hurt, C. S., Hindle, J. V., McCracken, L. M., Vasconcelos e Sa, D. A., Axell, S., Tapper, K., Stevens, J., Hirani, P. S., Salhab, M., et al. (2022) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720988901 · Cited by 55
Sesel, A.-L., Sharpe, L., & Naismith, S. L. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000486806 · Cited by 54
Meyer, B., Weiss, M., Holtkamp, M., Arnold, S., Brückner, K., Schröder, J., Scheibe, F., & Nestoriuc, Y. (2019) · Epilepsia · doi:10.1111/epi.14673 · Cited by 53
Cognitive Behaviour Therapy to Improve Mood in People with Epilepsy: A Randomised Controlled Trial
Gandy, M., Sharpe, L., Nicholson Perry, K., Thayer, Z., Miller, L., Boserio, J., & Mohamed, A. (2014) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2014.892530 · Cited by 52
Self-citationGold, S. M., Friede, T., Meyer, B., Moss-Morris, R. E., Hudson, J. L., Asseyer, S., Bellmann–Strobl, J., Leisdon, A., Ißels, L., Ritter, K., et al. (2023) · The Lancet Digital Health · doi:10.1016/s2589-7500(23)00109-7 · Cited by 51
Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment
Dobkin, R. D., Mann, S. L., Weintraub, D., Rodriguez, K. M., Miller, R. B., St. Hill, L., King, A., Gara, M. A., & Interian, A. (2021) · Movement Disorders · doi:10.1002/mds.28548 · Cited by 49 · cited 1×
“%) of the included PD trials were conducted by the same team, and reported large effects ( gs = 1.10 – 1.56) (Dobkin et al., 2011, 2020, 2021).”
BackgroundInfluentialMigliorini, C., Sinclair, A., Brown, D., Tonge, B., & New, P. (2016) · Spinal Cord · doi:10.1038/sc.2015.221 · Cited by 46
Bailey, E. M., Stevens, A. B., LaRocca, M. A., & Scogin, F. (2017) · Journal of Applied Gerontology · doi:10.1177/0733464815627956 · Cited by 45
Scott, A. J., Bisby, M. A., Heriseanu, A. I., Salameh, Y., Karin, E., Fogliati, R., Dudeney, J., Gandy, M., McLellan, L. F., Wootton, B., et al. (2023) · Clinical Psychology Review · doi:10.1016/j.cpr.2023.102353 · Cited by 45 · cited 4×
“This is also the case for study related factors known to influence treatment effects including the type of control and outcome measures used, baseline symptom severity, and risk of bias (Gandy et al., 2022; Scott et al., 2023).”
BackgroundResultInfluentialSelf-citationAnxiety is common and independently associated with clinical features of epilepsy
Clary, H. M. M., Snively, B. M., & Hamberger, M. J. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.05.024 · Cited by 44 · cited 1×
“Future development of interventions which emphasize anxiety is warranted, particularly as anxiety is prevalent and can occur without depression in NDs (Munger Clary, Snively, & Hamberger, 2018).”
BackgroundKirkness, C. J., Cain, K. C., Becker, K. J., Tirschwell, D. L., Buzaitis, A. M., Weisman, P. L., McKenzie, S., Teri, L., Kohen, R., Veith, R. C., et al. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2819-y · Cited by 43
Noble, A. J., Reilly, J., Temple, J., & Fisher, P. L. (2018) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-317997 · Cited by 43 · cited 1×
“These comparisons are important given some previous equivocal findings on the efficacy of these interventions for adults with common NDs such as epilepsy (Noble, Reilly, Temple, & Fisher, 2018) and MS (Sesel, Sharpe, & Naismith, 2018).”
ResultKraepelien, M., Schibbye, R., Månsson, K., Sundström, C., Riggare, S., Andersson, G., Lindefors, N., Svenningsson, P., & Kaldo, V. (2020) · Journal of Parkinson's Disease · doi:10.3233/jpd-191894 · Cited by 41
Wang, X., Li, J., Wang, C., & Lv, J. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5273 · Cited by 40
Niu, Y., Sheng, S., Chen, Y., Ding, J., Li, H., Shi, S., Wu, J., & Ye, D. (2022) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2021.106225 · Cited by 40
Alimohammadi, N., Pahlavanzadeh, S., & Abbasi, S. (2017) · Iranian Journal of Nursing and Midwifery Research · doi:10.4103/1735-9066.212987 · Cited by 38
Gandy, M., Karin, E., Fogliati, V. J., Meares, S., Nielssen, O., Titov, N., & Dear, B. F. (2018) · Rehabilitation Psychology · doi:10.1037/rep0000241 · Cited by 37 · cited 1×
“These modalities provide options for accessing psychological care remotely which may be preferable to some people with NDs, particularly those with mobility restrictions and cognitive difficulties (Gandy et al., 2018).”
BackgroundSelf-citationDavies, A., Rogers, J. M., Baker, K. S., Li, L., Llerena, J., das Nair, R., & Wong, D. K. (2023) · Neuropsychology Review · doi:10.1007/s11065-023-09625-z · Cited by 37 · cited 2×
“…in conjunction with cognitive remediation strategies to address functional difficulties that people with NDs experience (Gallagher et al., 2019), with evidence these combined treatments can improve quality of life, participation, and functioning in people with an ABI (Davies et al., 2023).”
BackgroundBahrani, S., Zargar, F., Yousefipour, G., & Akbari, H. (2017) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.44566 · Cited by 36
Meininger, L., Adam, J., von Wirth, E., Viefhaus, P., Woitecki, K., Walter, D., & Döpfner, M. (2022) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-022-00494-7 · Cited by 35 · cited 1×
“These results are promising considering the upsurge in teletherapy since the COVID-19 pandemic (Meininger et al., 2022) and general paradigm shift toward digital mental health interventions (Andersson, Titov, Dear, Rozental, & Carlbring, 2019).”
ResultJohnson, E. K., Fraser, R., Lashley, S., Barber, J. K., Brandling‐Bennett, E. M., Vossler, D. G., Miller, J. W., Caylor, L. M., & Warheit‐Niemi, T. (2020) · Epilepsia · doi:10.1111/epi.16530 · Cited by 34
Spruill, T. M., Friedman, D. J., Díaz, L., Butler, M. J., Goldfeld, K. S., O’Kula, S. S., Montesdeoca, J., Payano, L., Shallcross, A. J., Kaur, K., et al. (2021) · Translational Behavioral Medicine · doi:10.1093/tbm/ibab045 · Cited by 33
Internet-based treatment for depression in multiple sclerosis: A randomized controlled trial
Boeschoten, R. E., Dekker, J., Uitdehaag, B. M., Beekman, A. T., Hoogendoorn, A. W., Collette, E. H., Cuijpers, P., Nieuwenhuis, M. M., & van Oppen, P. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458516671820 · Cited by 29
Nazari, N., Sadeghi, M., Ghadampour, E., & Mirzaeefar, D. (2020) · BMC Psychology · doi:10.1186/s40359-020-00480-8 · Cited by 29
Little, A., Byrne, C., & Coetzer, R. (2021) · NeuroRehabilitation · doi:10.3233/nre-201544 · Cited by 29 · cited 1×
“The moderate effect sizes of those studies which used a severity criterion were more comparable to effect sizes observed in the general population (Cuijpers et al., 2023).”
Liu, Y.-E., Lv, J., Sun, F., Liang, J., Zhang, Y., Chen, J., & Jiang, W. (2023) · Brain and Behavior · doi:10.1002/brb3.3260 · Cited by 29
Dindo, L. N., Recober, A., Calarge, C. A., Zimmerman, B. M., Weinrib, A., Marchman, J. N., & Turvey, C. (2020) · Neurotherapeutics · doi:10.1007/s13311-019-00818-0 · Cited by 24
Assonov, D. O. (2021) · PubMed Central · doi:10.36131/cnfioritieditore20210503 · Cited by 24 · cited 1×
“%) of the included PD trials were conducted by the same team, and reported large effects ( gs = 1.10 – 1.56) (Dobkin et al., 2011, 2020, 2021).”
BackgroundInfluentialMindfulness-Based Cognitive Therapy as Migraine Intervention: a Randomized Waitlist Controlled Trial
Simshäuser, K., Pohl, R., Behrens, P., Schultz, C., Lahmann, C., & Schmidt, S. (2022) · International Journal of Behavioral Medicine · doi:10.1007/s12529-021-10044-8 · Cited by 23
Lin, R. S. Y., Yu, D. S. F., Chau, P. H., & Li, P. W. C. (2022) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2022.104381 · Cited by 23
Do distance-delivery group interventions improve depression in people with epilepsy?
Hum, K. M., Chan, C. J., Gane, J., Conway, L., McAndrews, M. P., & Smith, M. L. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.06.037 · Cited by 22
Gandy, M., Heriseanu, A. I., Dudeney, J. E., Bisby, M. A., Scott, A. J., Fisher, A. C., Hathway, T., Karin, E., Titov, N., & Dear, B. F. (2021) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2021.08.013 · Cited by 22 · cited 1×
“These include challenges associated with a lack of independence and sleep disturbances, and vulnerabilities associated with coping styles and cognitive difficulties (Cieza et al., 2015; Gandy et al., 2021).”
BackgroundSelf-citationSadeghi-Bahmani, D., Esmaeili, L., Mokhtari, F., Sadeghi Bahmani, L., Afsharzadeh, M., Shaygannejad, V., Mirmosayyeb, O., Goldstein-Piekarski, A. N., & Gross, J. J. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104029 · Cited by 22
Zhang, W., Du, Y., Yang, X., Wang, E., Fang, J., Liu, Z., Wu, S., Liu, Q., & Hu, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.832167 · Cited by 21 · cited 1×
“We found intervention efficacy was not significantly moderated by delivery mode, corroborating meta-analyses in the general population (Kriston, Liebherz, & Köhnen, 2022; Zhang et al., 2022), and expanding these findings by also including teletherapy.”
ResultGandy, M., Heriseanu, A. I., Balakumar, T., Karin, E., Walker, J., Hathway, T., Bisby, M. A., Scott, A. J., Dudeney, J., Fisher, A., et al. (2023) · Psychological Medicine · doi:10.1017/s0033291723000338 · Cited by 20 · cited 3×
“Thus, interventions with broader inclusion criteria would benefit from analyses that account for baseline symptom severity when analyzing intervention effects (Gandy et al., 2023).”
Self-citationAlsaadi, T. M., Kassie, S. A., Ali, O. M., Mozahem, K., Fardan, S. A., & Ahmed, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00263 · Cited by 19 · cited 2×
“Moreover, meta-analyses rarely explore psychological interventions for managing both depression and anxiety, despite their frequent coexistence across NDs (Alsaadi et al., 2019).”
BackgroundLi, D., Song, Y., Zhang, S., Qiu, J., Zhang, R., Wu, J., Wu, Z., Wei, J., Xiang, X., Zhang, Y., et al. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.109056 · Cited by 19 · cited 1×
“The magnitude of these effects are consistent with several smaller disorder-specific meta-analyses in PD (Ghielen et al., 2019), MS (Hind et al., 2014), and epilepsy (Li et al., 2023), as well as in adults with long-term physical health conditions (Scott et al., 2023).”
ResultExner, C., Doering, B. K., Conrad, N., Kuenemund, A., Zwick, S., Kühl, K., Nestler, S., & Rief, W. (2021) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2021.1908902 · Cited by 18
Sun, Q., Xu, H., Zhang, W., Zhou, Y., & Lv, Y. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s392403 · Cited by 18
Nazari, N., Aligholipour, A., & Sadeghi, M. (2020) · BMC Women's Health · doi:10.1186/s12905-020-01109-z · Cited by 17
Barua, U., Ahrens, J., Shao, R., MacKenzie, H., Wolfe, D., Sequeira, K., Teasell, R., Loh, E., & Mehta, S. (2024) · Brain Injury · doi:10.1080/02699052.2024.2309264 · Cited by 12 · cited 2×
“Finally, previous meta-analyses have not included clinical trials from the past five years (Barua et al., 2024; Ghielen et al., 2019; Hind et al., 2014; Wang et al., 2018).”
MethodResultSanders, S. E., Coppin, S., Moulson, H., Meola, J., & Meyrick, J. (2020) · Ansiedad y Estrés · doi:10.1016/j.anyes.2020.07.002 · Cited by 8 · cited 1×
“Most studies used some form of intervention tailoring to suit people with NDs, which is recommended as best practice (Karekla et al., 2019; Sanders, Coppin, Moulson, Meola, & Meyrick, 2020).”
BackgroundFeng, H., Wang, M., Zhao, H.-M., Hou, X., Xu, B., Gui, Q., Wu, G., Dong, X., Xu, Q., Shen, M.-Q., et al. (2022) · PubMed Central · Cited by 8
Gandy, M. (2023) · Australian Psychologist · doi:10.1080/00050067.2023.2183107 · Cited by 8 · cited 1×
“Additionally, while tailoring interventions for NDs, and offering remote treatment options have been suggested (Gallagher, McLeod, & McMillan, 2019; Gandy, 2020, 2023), the impact of these factors on outcomes remains unclear.”
BackgroundSelf-citationKriston, L., Liebherz, S., & Köhnen, M. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101763 · Cited by 4
Assonov, D. O. (2022) · Ukrainian Scientific Medical Youth Journal · doi:10.32345/usmyj.2(131).2022.32-43 · Cited by 2
Tips for working with people with neurological disorders
Gandy, M. (2020) · Cited by 2
Self-citationBarua, U., Ahrens, J., Mehta, S., & Shao, R. (2021) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2021.07.484 · Cited by 1 · cited 1×
“The smaller effects for epilepsy, stroke and TBI are also consistent with previous disorder-specific reviews in these conditions (Barua, Ahrens, Mehta, & Shao, 2021; Little, Byrne, & Coetzer, 2021).”
Result
Research works printed but not linked: 3
- Borenstein, M., Hedges, L., Higgins, J., & Rothstein, H. (2013). Comprehensive meta-analysis version 3. Englewood, NJ: Biostat.
- World Health Organisation. (2023). Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031. Geneva: World Health Organisation: Licence: CC BY-NC-SA 3.0 IGO.
- Schröder, J., Brückner, K., Fischer, A., Lindenau, M., Köther, U., Vettorazzi, E., & Moritz, S. (2014). Efficacy of a psychological online intervention for depression in people with epilepsy: A randomized controlled trial. Epilepsia, 55(12), 2069- 2076. doi: 10.1111/epi.12833 25410633 · DOI · Paper page
Cited by
Liu, C., Mou, L., Zhang, Y., Zhang, M., Yang, P., Ma, S., Zhang, M., Huang, J., Xiao, X., & Liu, J. (2025) · Seizure · doi:10.1016/j.seizure.2025.01.004 · Cited by 5
Integral Brain Health: a collaborative approach for psychiatry and neurology
Wasserman, D., Iosue, M., Avan, A., & Hachinski, V. (2025) · World Psychiatry · doi:10.1002/wps.21367 · Cited by 4
Providing integrated mental health care as a neurologist
Gandy, M., Baslet, G. C., Bennett, S. D., & Clary, H. M. M. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110368 · Cited by 5
“The most evidence-based and available intervention approaches for PWE are those grounded in the principles of Cognitive-Behavioral Therapy (CBT) [59,72].”
Self-citationZhu, X., & Lv, Q. (2025) · Health engineering. · doi:10.26599/he.2025.9460010 · Cited by 5
Yin, X., Cheng, J., Tian, W., Wen, C., Jiang, S., Xuan, Y., & Feng, X. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1592038 · Cited by 2
“Addressing these central symptoms through targeted interventions, such as cognitive training to improve memory (46) and strategies to manage intrusive thoughts (47), may help break this cycle.”
Metadata
- Authors
- Gandy, M., Woldhuis, T., Wu, W., Youssef, M., Bisby, M. A., Dear, B. F., Heriseanu, A. I., & Scott, A. J.
- Affiliations
- Macquarie University (AU)
- Corresponding author
- Gandy, Milena
- ORCID
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2024-09
- Volume
- 54
- Issue
- 12
- Pages
- 3237-3250
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- PMC
- PMC11496241
- OpenAlex
- W4402842650
- Cited by
- 20
- References
- 108
- Citations by year
- 2026: 10 · 2025: 9 · 2024: 1
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Psychological Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Multiple Sclerosis Australia
- Macquarie University
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Assessments
- Keywords
- cognitive behavioral therapy, depression, anxiety, neurological disorders, multiple sclerosis, epilepsy, stroke, treatment efficacy, symptom severity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

